A Prospective, Open-labeled, Multicenter Study of Galantamine on the Attention and Frontal Function of the Patients With Dementia of Alzheimer Type.
Phase of Trial: Phase IV
Latest Information Update: 21 Jan 2011
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 19 Oct 2007 Status changed from in progress to completed.
- 03 Dec 2005 New trial record.